Jones et al. [44] demonstrated that the magnitude of CD8+T-cell response to the latent EBV antigen LMP1/2A was elevated in patients who were HLA-A*02-positive compared to HLA-A*02-negative patients with cHL. The gene discussed is PDLIM7; the disease is classic Hodgkin lymphoma.